Home

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 800983.

EVO-NANO

Evolvable platform for programmable nanoparticle-based cancer therapies

(approved - launch on October 1, 2018)

HELLO

A FEW WORDS ABOUT US

 

We are consortium of 7 partners with shared goal of going far beyond the state of the art by creating entirely new nanoparticle design platform for cancer treatment capable of autonomously evolving both innovative and adaptive solutions.

 

Every partner in EVO-NANO has its own specific competencies and experience that is necessary to achieve the proposed objectives but with and overlap of knowledge that will enable an effective collaboration. EVO-NANO is organized around two research hubs: computing sciences and modelling (PFNS, UB, UWE and AAU) and experimental in vitro and in vivo cancer and nanoparticle research (IMDEA, VHIR and PCS). Partners with cross-disciplinary expertise are expected to work between these hubs to produce an integrated synthesis between in silico models and their material realizations.

WHAT WE DO

Modeling

 

Build an evolutionary model to simulate all the main aspects of nanoparticles dynamics in the body and tumour envrionment.

 

CONTACT US

Trg D. Obradovica 8

Lab. for Biophysics, Physics and Meteorology, Faculty of Agriculture, University of Novi Sad, 21000 Novi Sad

Serbia

office [at] evonano.eu

Tel: +381 21 4853290

Synthesis

 

Streamline synthesis of functionalized nanoparticles suggested by the evolutionary model

 

FOLLOW US

Facebook

Google +

Validation

 

Validate efficacy of artificially evolved nanoparticle designs using in vitro microfluidics and in vivo pre-clinical tests

 

© Copyright 2017. All Rights Reserved.